Cited by 899Cancer-related Molecular PathwaysHeat shock proteins researchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Open access

Kamijo, Takehiko, Weber, Jason D., Zambetti, Gerard, Zindy, Frederique, Roussel, Martine F., Sherr, Charles J.·1998·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.95.14.8292PMC PMC20969

Open this paper in CoChat — free account

Abstract

The INK4a-ARF locus encodes two proteins, p16(INK4a) and p19(ARF), that restrain cell growth by affecting the functions of the retinoblastoma protein and p53, respectively. Disruption of this locus by deletions or point mutations is a common event in human cancer, perhaps second only to the loss of p53. Using insect cells infected with baculovirus vectors and NIH 3T3 fibroblasts infected with ARF retrovirus, we determined that mouse p19(ARF) can interact directly with p53, as well as with the p53 regulator mdm2. ARF can bind p53-DNA complexes, and it depends upon functional p53 to transcriptionally induce mdm2 and the cyclin-dependent kinase inhibitor p21(Cip1), and to arrest cell proliferation. Binding of p19(ARF) to p53 requires the ARF N-terminal domain (amino acids 1-62) that is necessary and sufficient to induce cell cycle arrest. Overexpression of p19(ARF) in wild type or ARF-null mouse embryo fibroblasts increases the half-life of p53 from 15 to approximately 75 min, correlating with an increased p53-dependent transcriptional response and growth arrest. Surprisingly, when overexpressed at supra-physiologic levels after introduction into ARF-null NIH 3T3 cells or mouse embryo fibroblasts, the p53 protein is handicapped in inducing this checkpoint response. In this setting, reintroduction of p19(ARF) restores p53's ability to induce p21(Cip1) and mdm2, implying that, in addition to stabilizing p53, ARF modulates p53-dependent function through an additional mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.95.14.8292

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Self-citation
QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES
Todaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,747
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100

Show all 61 references

Research works printed but not linked: 10

M Hollstein, K Rice, M S Greenblatt, T Soussi, R Fuchs, T Sorlie, E Hovig, B Smith-Sorensen, R Montesano, C C Harris Nucleic Acids Res 22, 3551–3555 (1994).
D Duro, O Bernard, V Della Valle, R Berger, C-J Larsen Oncogene 11, 21–29 (1995).
L Mao, A Merlo, G Bedi, G I Shapiro, C D Edwards, B J Rollins, D Sidransky Cancer Res 55, 2995–2997 (1995).
S Stone, P Jiang, P Dayananth, S V Tavtigian, H Katcher, D Parry, G Peters, A Kamb Cancer Res 55, 2988–2994 (1995).
10.1128/mcb.13.7.4107-4114.1993 · DOI
P W Hinds, C A Finlay, R S Quartin, S J Baker, E R Fearon, B Vogelstein, A J Levine Cell Growth Diff 1, 571–580 (1990).
10.1128/mcb.7.8.2745-2752.1987 · DOI
10.1126/science.256.5058.827 · DOI
10.1128/mcb.2.9.1044-1051.1982 · DOI
G Shaulsky, N Goldfinger, M S Tosky, A J Levine, V Rotter Oncogene 6, 2055–2065 (1991).

Sorted by citations

Items 201–300 of 896

Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
The impact of the Cancer Genome Atlas on lung cancer
Chang, J. T.-H., Lee, Y. M., & Huang, R. S. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.001 · Cited by 125
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O’Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
Defining the molecular basis of Arf and Hdm2 interactions
Bothner, B. B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J., & Kriwacki, R. W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5110 · Cited by 122
Self-citation
Multiple Stress Signals Activate Mutant p53 In Vivo
Suh, Y., Post, S. M., Elizondo-Fraire, A. C., Macció, D. R., Jackson, J. G., El‐Naggar, A. K., Pelt, C. V., Terzian, T., & Lozano, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0459 · Cited by 119
Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice.
Lu, Y.-P., Lou, Y. R., Li, X. H., Xie, J., Brash, D. E., Huang, M.-N., & Conney, A. H. (2000) · PubMed · Cited by 119
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development
McKeller, R. N., Fowler, J. L., Cunningham, J. J., Warner, N., Smeyne, R. J., Zindy, F., & Skapek, S. X. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052484199 · Cited by 120
Self-citation
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy
Woods, S. J., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.007 · Cited by 120
Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 117
Self-citation
Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis
Ito, M., Barys, L., O'Reilly, T., Young, S., Gorbatcheva, B., Monahan, J., Zumstein-Mecker, S., Choong, P. F., Dickinson, I., Crowe, P., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2050 · Cited by 115
T Cells Associated with Tumor Regression Recognize Frameshifted Products of the CDKN2A Tumor Suppressor Gene Locus and a Mutated HLA Class I Gene Product
Huang, J., El‐Gamil, M., Dudley, M. E., Li, Y. F., Rosenberg, S. A., & Robbins, P. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6057 · Cited by 115
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication
Izumi, T., Io, K., Matsui, M., Shirakawa, K., Shinohara, M., Nagai, Y., Kawahara, M., Kobayashi, M., Kondoh, H., Misawa, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008076107 · Cited by 109
Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2
Saha, A., Murakami, M., Kumar, P., Bajaj, B. G., Sims, K., & Robertson, E. S. (2009) · Journal of Virology · doi:10.1128/jvi.02408-08 · Cited by 120
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 112
Mécanismes moléculaires contrôlant le cycle cellulaire : aspects fondamentaux et implications en cancérologie
Viallard, J.-F., Lacombe, F., Belloc, F., Pellegrin, J., & Reiffers, J. J. (2001) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(01)00087-7 · Cited by 123
Myc-ARF (Alternate Reading Frame) Interaction Inhibits the Functions of Myc
Datta, A., Nag, A., Pan, W., Hay, N., Gartel, A. L., Colamonici, O. R., Mori, Y., & Raychaudhuri, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312305200 · Cited by 113
Determination of the frequency of the common 657Del5 Nnijmegen breakage syndrome mutation in the German population: No association with risk of breast cancer
Carlomagno, F., Chang-Claude, J. C., Dunning, A. M., & Ponder, B. A. J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199908)25:4 · Cited by 48
West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus
Yang, M.-R., Lee, S. R., Oh, W., Lee, E., Yeh, J., Nah, J., Joo, Y.-S., Shin, J., Lee, H., Pyo, S., et al. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01027.x · Cited by 113
Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF
Rizos, H., Darmanian, A., Holland, E. A., Mann, G. J., & Kefford, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105299200 · Cited by 113
Telomere dysfunction alters the chemotherapeutic profile of transformed cells
Lee, K.-H., Rudolph, K. L., Ju, Y.-J., Greenberg, R. A., Cannizzaro, L. A., Chin, L., Weiler, S. R., & DePinho, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629198 · Cited by 111
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 111
DNA Damage Disrupts the p14ARF-B23(Nucleophosmin) Interaction and Triggers a Transient Subnuclear Redistribution of p14ARF
Lee, C., Smith, B. A., Bandyopadhyay, K., & Gjerset, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1759 · Cited by 106
Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis
Hemmati, P., Gillissen, B. F., von Haefen, C., Wendt, J., Stärck, L., Güner, D., Dörken, B., & Daniel, P. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205458 · Cited by 109
Differential effects of p19 Arf and p16 Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages
Randle, D. H., Zindy, F., Sherr, C. J., & Roussel, M. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171217498 · Cited by 108
Self-citation
Critical Role of Cysteine Residue 81 of Macrophage Migration Inhibitory Factor (MIF) in MIF-induced Inhibition of p53 Activity
Jung, H., Seong, H., & Ha, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800050200 · Cited by 106
Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms
Silva, J., Silva, J. M., Domínguez, G., García, J. M., Cantos, B., Rodríguez, R., Larrondo, F. J., Provencio, M., España, P., & Bonilla, F. (2003) · The Journal of Pathology · doi:10.1002/path.1297 · Cited by 107
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesisPreprint
Inoue, K., Wen, R., Rehg, J. E., Adachi, M., Cleveland, J. L., Roussel, M. F., & Sherr, C. J. (2000) · Genes & Development · doi:10.1101/gad.14.14.1797 · Cited by 107
Self-citation
Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomasPreprint
Inoue, K., Zindy, F., Randle, D. H., Rehg, J. E., & Sherr, C. J. (2001) · Genes & Development · doi:10.1101/gad.929901 · Cited by 106
Self-citation
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Regulation of p53 - insights into a complex process
Boehme, K. A., & Blattner, C. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903401507 · Cited by 107
NM23-H1 Tumor Suppressor and Its Interacting Partner STRAP Activate p53 Function
Jung, H., Seong, H., & Ha, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705181200 · Cited by 105
Novel aspects of oxidative stress-associated carcinogenesis
Toyokuni, S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1373 · Cited by 104
Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion
Khan, S. H., Moritsugu, J., & Wahl, G. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3266 · Cited by 103
p14 ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress
Eymin, B., Claverie, P., Salon, C., Leduc, C., Col, E., Brambilla, E. M., Khochbin, S., & Gazzéri, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02240-05 · Cited by 111
Myc-Mediated Proliferation and Lymphomagenesis, but Not Apoptosis, Are Compromised by E2f1 Loss
Baudino, T. A., Maclean, K. H., Brennan, J. A., Parganas, E., Yang, C., Aslanian, A., Lees, J. A., Sherr, C. J., Roussel, M. F., & Cleveland, J. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00102-3 · Cited by 101
Self-citation
Interruption of progerin–lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype
Lee, S.-J., Jung, Y., Yoon, M.-H., Kang, S., Oh, A.-Y., Lee, J.-H., Jun, S.-Y., Woo, T.-G., Chun, H.-Y., Kim, S. K., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84164 · Cited by 108
Concurrent Inactivation of RB1 and TP53 Pathways in Anaplastic Oligodendrogliomas
Watanabe, T., Yokoo, H., Yokoo, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1181 · Cited by 103
INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
Pinyol, M., Hernández, L., Martı́nez, A., Cobo, F., Hernandez, S. F., Beà, S., López‐Guillermo, A., Nayach, I., Palacı́n, A., Nadal, A., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65071-7 · Cited by 102
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RASG12V oncogene
Schreiber, F. S., Deramaudt, T. B., Brunner, T. B., Boretti, M. I., Gooch, K. J., Stoffers, D. A., Bernhard, E. J., & Rustgi, A. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.058 · Cited by 104
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
Lindström, M. S., Klangby, U., & Wiman, K. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204303 · Cited by 101
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 99
Cell cycle regulatory functions of the human oncoprotein MDM2.
Deb, S. P. (2003) · PubMed · Cited by 96
The role of p53 in pigmentation, tanning and melanoma
Box, N. F., & Terzian, T. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00495.x · Cited by 95
Modelling mutational landscapes of human cancers in vitro
Olivier, M., Weninger, A., Ardin, M., Hušková, H., Castells, X., Vallée, M., McKay, J., Nedelko, T., Muehlbauer, K., Marusawa, H., et al. (2014) · Scientific Reports · doi:10.1038/srep04482 · Cited by 94
Downregulation of rRNA Transcription Triggers Cell Differentiation
Hayashi, Y., Kuroda, T., Kishimoto, H., Wang, C., Iwama, A., & Kimura, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098586 · Cited by 94
Nucleolar Proteins Suppress Caenorhabditis elegans Innate Immunity by Inhibiting p53/CEP-1
Fuhrman, L. E., Goel, A., Smith, J. P., Shianna, K. V., & Aballay, A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000657 · Cited by 92
Roles of ubiquitin signaling in transcription regulation
Hammond-Martel, I., Yu, H., & Affar, E. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.009 · Cited by 98
Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization
Rizos, H., Darmanian, A., Mann, G. J., & Kefford, R. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203629 · Cited by 95
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2
Xirodimas, D. P., Chisholm, J., Desterro, J. M. S., Lane, D. P., & Hay, R. T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03310-0 · Cited by 94
ARF Induces Autophagy by Virtue of Interaction with Bcl-xl
Pimkina, J. S., Humbey, O., Zilfou, J. T., Jarník, M., & Murphy, M. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804705200 · Cited by 96
Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62547-3 · Cited by 93
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
Saxena, A. D., Rorie, C. J., Dimitrova, D. D., Daniely, Y., & Borowiec, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209714 · Cited by 94
Oncogenic Ras Induces p19ARF and Growth Arrest in Mouse Embryo Fibroblasts Lacking p21Cip1 and p27Kip1 without Activating Cyclin D-dependent Kinases
Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003417200 · Cited by 92
Self-citation
Contribution of two independent MDM2-binding domains in p14ARF to p53 stabilization
Lohrum, M. A. E., Ashcroft, M. A., Kubbutat, M. H. G., & Vousden, K. H. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00472-3 · Cited by 91
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer
Kawamoto, K., Enokida, H., Gotanda, T., Kubo, H., Nishiyama, K., Kawahara, M., & Nakagawa, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.072 · Cited by 91
Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses
Vecil, G. G., & Lang, F. F. (2003) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000003653.45635.32 · Cited by 90
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 91
The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation
Brown, L. M., & Benchimol, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507951200 · Cited by 91
Correlations of partial and extensive methylation at the p14ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors
Zheng, S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.11.2057 · Cited by 89
A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
Zhu, J. W., DeRyckere, D., Li, F. X., Wan, Y. Y., & DeGregori, J. V. (1999) · PubMed · Cited by 89
Effect of Intragastric Application ofN-Methylnitrosourea inp53 Knockout Mice
Ohgaki, H., Fukuda, M., Tohma, Y., Huang, H., Stoica, G., Tatematsu, M., & Donehower, L. A. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200006)28:2 · Cited by 22
From p63 to p53 across p73
Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E. R., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 87
Promoter hypermethylation and homozygous deletion of the p14 ARF and p16 INK4a genes in oligodendrogliomas
Watanabe, T., Nakamura, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000343 · Cited by 88
Lentivector-Mediated Transfer of Bmi-1 and Telomerase in Muscle Satellite Cells Yields a Duchenne Myoblast Cell Line with Long-Term Genotypic and Phenotypic Stability
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 86
The MDM2 gene family
Mendoza, M. J., Mandani, G., & Momand, J. A. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2013-0027 · Cited by 88
The emerging era of genomic data integration for analyzing splice isoform function
Li, H. D., Menon, R., Omenn, G. S., & Guan, Y. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.05.005 · Cited by 86
Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes
Abreu, R. D. S., Sánchez-Díaz, P. C., Vogel, C., Burns, S. C., Ko, D., Burton, T. L., Vo, D. T., Chennasamudaram, S., Le, S., Shapiro, B. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809605200 · Cited by 87
The RING domain of Mdm2 can inhibit cell proliferation.
Dang, J., Kuo, M.-L., Eischen, C. M., Stepanova, L., Sherr, C. J., & Roussel, M. F. (2002) · PubMed · Cited by 86
Self-citation
Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein
Kimura, S. H., & Nojima, H. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00564.x · Cited by 85
Tbx3, the ulnar‐mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53‐independent pathway
Jerome‐Majewska, L. A., Jenkins, G. P., Ernstoff, E., Zindy, F., Sherr, C. J., & Papaioannou, V. E. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20575 · Cited by 86
Self-citation
p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo
Tolbert, D., Lu, X., Yin, C., Tantama, M., & Dyke, T. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.370-377.2002 · Cited by 85
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 85
Targeting p53-MDM2-MDMX Loop for Cancer Therapy
Zhang, Q., Zeng, S. X., & Lu, H. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_16 · Cited by 85
Inhibition of the E2F‐1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid β‐peptide‐induced apoptosis of PC12 Cells
Ramalho, R. M., Ribeiro, P. S., Solá, S., Castro, R. E., Steer, C. J., & Rodrigues, C. M. P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02517.x · Cited by 84
Acridine derivatives activate p53 and induce tumor cell death through bax
Wang, W., Ho, W. C., Dicker, D. T., MacKinnon, C., Winkler, J. D., Marmorstein, R., & El‐Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.8.2134 · Cited by 83
Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
Wang, W., Zhang, X., Qin, J., Voruganti, S., Nag, S. A., Wang, M., Wang, H., & Zhang, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041586 · Cited by 81
Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas
Yoshino, A., Katayama, Y., Ogino, A., Watanabe, T., Yachi, K., Ohta, T., Komine, C., Yokoyama, T., & Fukushima, T. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9316-9 · Cited by 82
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
Perrone, F., Tabano, S. M., Colombo, F., Dagrada, G. P., Birindelli, S., Gronchi, A., Colecchia, M., Pierotti, M. A., & Pilotti, S. (2003) · PubMed · Cited by 81
BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid Tissues
Muthalagu, N., Junttila, M. R., Wiese, K. E., Wolf, E., Morton, J. P., Bauer, B., Evan, G. I., Eilers, M., & Murphy, D. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.057 · Cited by 82
The INK4A/ARF Locus: Role in Cell Cycle Control and Apoptosis and Implications for Glioma Growth
Ivanchuk, S. M., Mondal, S., Dirks, P. B., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010632309113 · Cited by 81
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk
Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79
p53-Induced Apoptosis as a Safeguard against Cancer
Asker, C., Wiman, K. G., & Selivanova, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1446 · Cited by 79
Oncogenic Ras-mediated Cell Growth Arrest and Apoptosis are Associated with Increased Ubiquitin-dependent Cyclin D1 Degradation
Shao, J., Sheng, H., DuBois, R. N., & Beauchamp, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002235200 · Cited by 81
Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2
Nie, J., Xie, P., Liu, L., Xing, G., Chang, Z., Yin, Y., Tian, C., He, F., & Zhang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126920 · Cited by 79
Choosing anticancer drug targets in the postgenomic era
Kaelin, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8888 · Cited by 79
Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma
Grønbæk, K., Brown, P. D. N., Møller, M. B., Nedergaard, T., Ralfkiaer, E. M., Mӧller, P., Zeuthen, J., & Guldberg, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401901 · Cited by 79
Acquisition of p16INK4Aandp15INK4BGene Abnormalities Between Initial Diagnosis and Relapse in Children With Acute Lymphoblastic Leukemia
Maloney, K. W., McGavran, L., Odom, L. F., & Hunger, S. P. (1999) · Blood · doi:10.1182/blood.v93.7.2380 · Cited by 77
Scission of the p53-MDM2 Loop by Ribosomal Proteins
Zhou, X. Y., Liao, J.-M., Liao, W.-J., & Lu, H. (2012) · Genes & Cancer · doi:10.1177/1947601912455200 · Cited by 82
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 82
High prevalence of p16 genetic alterations in head and neck tumours
Miracca, E. C., Kowalski, L. P., & Nagai, M. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690747 · Cited by 78
Developmental defects and tumor predisposition in Rb mutant mice
Vooijs, M., & Berns, A. J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202999 · Cited by 77
DNA damage response to the Mdm2 inhibitor Nutlin-3
Verma, R., Rigatti, M. J., Belinsky, G. S., Godman, C. A., & Giardina, C. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.020 · Cited by 77
Frequent alteration of p16 INK4a /p14 ARF and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14 ARF expression both correlate with poor prognosis
Oda, Y., Yamamoto, H., Takahira, T., Kobayashi, C., Kawaguchi, K., Tateishi, N., Nozuka, Y., Tamiya, S., Tanaka, K., Matsuda, S., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1848 · Cited by 76
Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis
Lessard, J. A., & Sauvageau, G. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00081-x · Cited by 76
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78
Self-citation
30 years and a long way into p53 research
Hainaut, P. L., & Wiman, K. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70198-6 · Cited by 80
Cancer and Apoptosis
Chaudhry, G.-E.-S., Akim, A. M., Sung, Y. Y., & Muhammad, T. S. T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2553-8_16 · Cited by 83
CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells
Qi, C., Mårtensson, A., Mattioli, M., Dalla‐Favera, R., Lobanenkov, V. V., & Morse, H. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237127100 · Cited by 73
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 77

Authors: Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J.
Affiliations: St. Jude Children's Research Hospital (US)
Howard Hughes Medical Institute and Departments of Tumor Cell Biology and Biochemistry, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN 38105
Corresponding author: Sherr, Charles J.
ORCID: Kamijo, Takehiko
Weber, Jason D.
Zambetti, Gerard
Roussel, Martine F.
Sherr, Charles J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1998-07-07
Volume: 95
Issue: 14
Pages: 8292-8297
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.95.14.8292
PMC: PMC20969
OpenAlex: W2141529421
Cited by: 899
References: 61
Citations by year: 2026: 5 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 26 · 2015: 21 · 2014: 33 · 2013: 28 · 2012: 34
FWCI: 31.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Institutes of Health (CA21765))
National Cancer Institute (R01CA063230, CA-71907, CA-63230, CA21765, P30CA021765, P01CA071907)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: p19ARF, p53, MDM2, INK4a/ARF locus, p16INK4a, protein-protein interaction, p53 stabilization, p21 Cip1, cell cycle arrest, p53-dependent transcription, tumor suppressor, p53 DNA binding, N-terminal domain
MeSH terms: Animals, Humans, Neoplasm Proteins, Nuclear Proteins, Proteins, Proto-Oncogene Proteins, Retroviridae, Transfection, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, 3T3 Cells, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks